Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Zacks's profile

Blog
2026 Is Poised For Another Year Of Double-Digit Gains, Despite Recent Volatility: https://staticx-tuner.zacks.com/images/articles/main/f8/154275.webp
2026 Is Poised For Another Year Of Double-Digit Gains, Despite Recent Volatility

Stocks have been under pressure over the last month, in large part due to the Middle East conflict.Although, markets were already exhibiting a bit of weakness prior to that with big tech and

3 Reasons Growth Investors Will Love Sezzle Inc. (SEZL)
3 Reasons Growth Investors Will Love Sezzle Inc. (SEZL)

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to

Chewy (CHWY) is an Incredible Growth Stock: 3 Reasons Why
Chewy (CHWY) is an Incredible Growth Stock: 3 Reasons Why

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. However, it isn't

Can Agenus (AGEN) Run Higher on Rising Earnings Estimates?
Can Agenus (AGEN) Run Higher on Rising Earnings Estimates?

Agenus (AGEN) could be a solid choice for investors given the company's remarkably improving earnings outlook. While the stock has been a strong performer lately, this trend might continue since

Will United Therapeutics (UTHR) Beat Estimates Again in Its Next Earnings Report?
Will United Therapeutics (UTHR) Beat Estimates Again in Its Next Earnings Report?

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider United